Product Information
CLOBAZAM 2.5 MG/ML SUSPENSION is a generic product labeled by Bionpharma Inc., priced at $0.1608 per ML under NDC 69452011645. Its NADAC has been published 388 times since Jan 23, 2019.
Strength
2.5 mg/mL
Manufacturer
Bionpharma Inc.NDC
69452011645
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOBAZAMApproval Type
Generic (ANDA)
FDA Application
ANDA208819On Market Since
10/20/2017
Pharmacological Classes
Price Statistics
The NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has been published 388 times since Jan 23, 2019, and over the history we have for it it has declined 88.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1608 per ML |
|---|---|
| All-time high | $1.4486 (Mar 13, 2019) |
| All-time low | $0.1530 (May 20, 2026) |
| 52-week high | $0.1928 |
| 52-week low | $0.1530 |
| Median price | $0.3773 |
| Average price | $0.4452 |
| Largest weekly change | -41.1% (Sep 23, 2020) |
| Weeks tracked | 388 |
| Tracking since | Jan 23, 2019 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOBAZAM 2.5 MG/ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBAZAM 2.5 MG/ML SUSPENSION, manufactured by Bionpharma Inc., is $0.1608 per ML (NDC 69452011645), effective Jun 24, 2026.
How has the price of CLOBAZAM 2.5 MG/ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has declined 88.0%. It has been tracked across 388 weekly CMS publications since Jan 23, 2019.
What are the highest and lowest recorded NADAC prices for CLOBAZAM 2.5 MG/ML SUSPENSION?
Since Jan 23, 2019, the NADAC for CLOBAZAM 2.5 MG/ML SUSPENSION has ranged from a low of $0.1530 (May 20, 2026) to a high of $1.4486 (Mar 13, 2019), with a median of $0.3773 per ML.
Are there cheaper alternatives to CLOBAZAM 2.5 MG/ML SUSPENSION?
5 NADAC-published products share the same active ingredient, strength, and dosage form as CLOBAZAM 2.5 MG/ML SUSPENSION, but none are currently priced below it.
Who manufactures CLOBAZAM 2.5 MG/ML SUSPENSION?
CLOBAZAM 2.5 MG/ML SUSPENSION (NDC 69452011645) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification